Recurrence/regrowth was not associated with tumor size, but the percentage obtained herein was consistent with that described by other authors, who reported recurrence rates in grade I meningiomas of up to 20%, particularly tumors showing higher positivity for Ki67 (5, 6, 11, 45, 49–53). This evidence concerns the gene MKI67 and neoplasm.